We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
-14.38%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$1.42B
AUM Growth
-$452M
Cap. Flow
+$71.6M
Cap. Flow %
5.06%
Top 10 Hldgs %
29.79%
Holding
375
New
15
Increased
44
Reduced
27
Closed
103

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$46.6M
2
GM icon
General Motors
GM
+$45.2M
3
OXY.WS icon
Occidental Petroleum Corp Warrants
OXY.WS
+$33.8M
4
LEN icon
Lennar Class A
LEN
+$18.2M
5
VCSA
Vacasa, Inc. Class A Common Stock
VCSA
+$16M

Top Sells

Rank Stock Value
1
HLF icon
Herbalife
HLF
+$43.7M
2
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$20.7M
3
HES
Hess
HES
+$13.6M
4
USO icon
United States Oil Fund
USO
+$8.66M
5
GROV icon
Grove Collaborative
GROV
+$8.35M

Sector Composition

Rank Sector Weight
1 Financials 33.53%
2 Healthcare 23.26%
3 Consumer Discretionary 10.28%
4 Industrials 7.33%
5 Communication Services 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRS
26
IRSA Inversiones y Representaciones
IRS
$1.3B
$17.6M 1.24%
4,677,427
+1,407,260
+43% +$6.42M
ATRA icon
27
Atara Biotherapeutics
ATRA
$101M
$15.9M 1.13%
81,800
+8,600
+12% +$1.4M
PRG icon
28
PROG Holdings
PRG
$1.42B
$15.5M 1.1%
940,000
-21,700
-2% -$555K
GTAC
29
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$15.3M 1.08%
1,535,000
– –
RKTA
30
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$14.7M 1.04%
1,500,000
– –
TCOA
31
DELISTED
Zalatoris Acquisition Corp.
TCOA
$14.6M 1.03%
1,485,000
– –
PANA
32
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$14.4M 1.02%
1,480,000
– –
TGTX icon
33
TG Therapeutics
TGTX
$8.55B
$14M 0.99%
3,300,000
+701,105
+27% +$4.38M
CND
34
DELISTED
Concord Acquisition Corp.
CND
$13.3M 0.94%
1,340,000
– –
AMLX icon
35
Amylyx Pharmaceuticals
AMLX
$3.64B
$13M 0.92%
677,714
– –
PHAT icon
36
Phathom Pharmaceuticals
PHAT
$622M
$12.2M 0.86%
1,440,000
+1,085,000
+306% +$11.2M
IMTX icon
37
Immatics
IMTX
$1.32B
$12.1M 0.85%
1,385,600
+125,600
+10% +$994K
CLDI icon
38
Calidi Biotherapeutics
CLDI
$3.02M
$11.9M 0.84%
625
– –
SRSA
39
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$11.9M 0.84%
1,200,000
– –
IVVD icon
40
Invivyd
IVVD
$237M
$11.8M 0.83%
3,603,637
+1,253,637
+53% +$3.93M
ORIA
41
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$11.7M 0.82%
1,199,000
– –
USO icon
42
CALL
United States Oil Fund
USO
$2.27B
$11.7M 0.82%
145,000
– –
VCSA
43
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$11.1M 0.78%
192,500
+152,168
+377% +$16M
MGTX icon
44
MeiraGTx Holdings
MGTX
$1.23B
$10.9M 0.77%
1,440,000
+85,000
+6% +$825K
APMI
45
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$10.6M 0.75%
1,099,999
+3
+0% +$29
DRAY
46
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$9.95M 0.7%
999,999
– –
BTWN
47
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$9.91M 0.7%
998,940
– –
PTOC
48
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$9.77M 0.69%
1,000,000
– –
ARYE
49
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$9.72M 0.69%
1,000,000
– –
MBTC
50
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$9.68M 0.68%
950,000
– –
1
2
3 4 5

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, 683 Capital Management held 375 positions worth $1.42B, down 24% from $1.87B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

683 Capital Management deployed $71.6M of net new capital in Q2 2022, opening 15 new positions and adding to 44 existing holdings. Its largest new stake was General Motors: 1,205,400 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Lakefront Biotherapeutics American Depositary Shares, an estimated $20.7M trimmed.

  • 683 Capital Management's largest Q2 2022 buy was General Motors: 1,205,400 shares worth $38.3M.
  • 683 Capital Management added most to Carvana in Q2 2022, an estimated $46.6M increase.
  • 683 Capital Management's biggest Q2 2022 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $20.7M.
  • 683 Capital Management fully exited Herbalife in Q2 2022, selling an estimated $43.7M.
  • 683 Capital Management's ten largest holdings make up 30% of its $1.42B portfolio in Q2 2022.
  • 683 Capital Management opened 15 new positions and closed 103 in Q2 2022.
  • 683 Capital Management's portfolio value fell 24% quarter-over-quarter to $1.42B.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.